Pachydermoperiostosis of the complete type: A novel missense mutation c.101T > C in the SLCO2A1 gene.

[1]  T. Matsui,et al.  A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter , 2015, PLoS genetics.

[2]  A. Shiohama,et al.  The complete type of pachydermoperiostosis: a novel nonsense mutation p.E141* of the SLCO2A1 gene. , 2014, Journal of dermatological science.

[3]  H. Okano,et al.  Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis. , 2012, Journal of dermatological science.

[4]  Colin A. Johnson,et al.  Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis , 2012, Human mutation.

[5]  Wei-wei Hu,et al.  Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. , 2012, American journal of human genetics.

[6]  M. Martínez-Lavín.  Miscellaneous non-inflammatory musculoskeletal conditions. Pachydermoperiostosis. , 2011, Best practice & research. Clinical rheumatology.

[7]  Naiana Bittencourt de Sá,et al.  Pachydermoperiostosis: the complete form of the syndrome. , 2011, Anais brasileiros de dermatologia.

[8]  D. Bonthron,et al.  Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy , 2008, Nature Genetics.

[9]  B. Dallapiccola,et al.  Pachydermoperiostosis: an update , 2005, Clinical genetics.

[10]  L. Bianchi,et al.  Pachydermoperiostosis: study of epidermal growth factor and steroid receptors , 1995, The British journal of dermatology.